Gemmer Asset Management LLC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 278 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.

Quarter-by-quarter ownership
Gemmer Asset Management LLC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2022$4,000
-63.6%
95
-45.1%
0.00%
-100.0%
Q4 2021$11,000
+83.3%
173
+82.1%
0.00%0.0%
Q3 2021$6,000
-57.1%
95
-43.8%
0.00%
-50.0%
Q2 2021$14,000
+133.3%
169
+77.9%
0.00%
+100.0%
Q1 2021$6,000
-14.3%
950.0%0.00%0.0%
Q4 2020$7,000
+75.0%
950.0%0.00%0.0%
Q3 2020$4,000
-20.0%
95
-12.0%
0.00%0.0%
Q2 2020$5,000
+400.0%
108
+184.2%
0.00%
Q1 2020$1,000
-83.3%
38
-56.3%
0.00%
-100.0%
Q4 2019$6,000
+200.0%
870.0%0.00%
Q3 2019$2,0000.0%870.0%0.00%
-100.0%
Q2 2019$2,000870.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q2 2022
NameSharesValueWeighting ↓
WESTERN FINANCIAL Corp 820,346$62,945,00041.38%
Johnson & Johnson Innovation - JJDC, Inc. 3,260,869$250,206,00032.27%
Aquilo Capital Management, LLC 365,926$28,078,0005.84%
L1 Capital Pty Ltd 298,687$23,127,0004.32%
First Light Asset Management, LLC 704,449$54,052,0004.00%
ACUTA CAPITAL PARTNERS, LLC 139,000$10,665,0002.90%
Evolutionary Tree Capital Management, LLC 48,265$3,703,0002.82%
Parkman Healthcare Partners LLC 127,171$9,758,0002.50%
Capital Impact Advisors, LLC 88,183$6,766,0001.66%
Tri Locum Partners LP 56,003$4,297,0001.56%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders